Clinicopathological and prognostic value of hypoxia-inducible factor-1 α in breast cancer: a meta-analysis including 5177 patients

ConclusionHIF-1 α might serve as an independent prognostic biomarker and a promising therapeutic target for BC. Future large-scale prospective randomized trials are needed to confirm our findings.

http://link.springer.com/10.1007/s12094-020-02332-8

Source: Clinical and Translational Oncology - March 11, 2020 Category: Cancer & Oncology Source Type: research